HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Immunobeads test (antibody coated polyacrylamide beads) in the immunological characterization of lymphoproliferative disorders.

Abstract
Three groups of patients with immunoproliferative disorders (15 multiple myeloma, 11 non-Hodgkin's lymphoma, 21 chronic lymphocytic leukemia) were studied by immunological characterization and compared to a group of 20 normal subjects (controls) using anti-immunoglobulin coated polyacrylamide beads (T-B Quantigen test, QT), erythrocyte rosettes (ER), surface immunoglobulin (SIg), and monoclonal antibodies for T and B cells (OKT3; OKT11; OKT8; OKT4; IaDR); null cells (NC) and double marker (DM) cells were also considered. The values for normal subjects for T-B, NC and DM cells were comparable. Results for the patient groups strikingly differed. There were progressively larger differences between the T and B percentages obtained with different techniques. The largest differences were seen in patients with chronic lymphocytic leukemia and the smallest in multiple myeloma patients; values were intermediate in non-Hodgkin lymphoma. The different findings were related to the number of DM cells (ER+, SIg+ QT+) and the different tests used. The importance of these findings in the diagnostic approach to lymphoproliferative disorders is discussed.
AuthorsT Chisesi, M Vespignani, G Capnist
JournalThe International journal of biological markers (Int J Biol Markers) 1987 Sep-Dec Vol. 2 Issue 3 Pg. 173-6 ISSN: 0393-6155 [Print] ITALY
PMID3502472 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Acrylic Resins
  • Antibodies, Monoclonal
  • Immunoglobulins
  • polyacrylamide
Topics
  • Acrylic Resins
  • Antibodies, Monoclonal
  • B-Lymphocytes (analysis, classification)
  • Humans
  • Immunoglobulins
  • Lymphocytes, Null (analysis)
  • Lymphoproliferative Disorders (blood, diagnosis)
  • Microspheres
  • Phenotype
  • Rosette Formation
  • T-Lymphocytes (analysis, classification)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: